J&J | JNJ - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 2.94M 2026-03
Amgen USD 541M 1000K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Baxter International USD 517M 549K 2026-06
Bayer EUR 982.42M 0 2026-03
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Biogen USD 146.7M 200K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
CONMED USD 29.99M 157K 2026-06
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Globus Medical USD 135.67M 611K 2026-03
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 1.38M 2025-12
Merck USD 2.47B 4.93M 2026-03
Merit Medical Systems USD 59.71M 55K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teva Pharmaceutical Industries USD 1.16B 1000K 2026-06
Vertex Pharmaceuticals USD 253.3M 900K 2026-06
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06
Zoetis USD 414.15M 6.19M 2026-06